Zobrazeno 1 - 10
of 760
pro vyhledávání: ''
Autor:
Koji Matsuo, Jason D. Wright, Lynda D. Roman, Laila I. Muderspach, Caroline J. Violette, Varun U. Khetan, Maximilian Klar, David J. Nusbaum
Publikováno v:
Gynecologic Oncology. 164:46-52
To examine trends and outcomes related to sentinel lymph node (SLN) biopsy for stage II endometrial cancer.This is a retrospective observational cohort study querying the National Cancer Institute's Surveillance, Epidemiology, and End Results Program
Publikováno v:
Gynecologic Oncology. 164:62-67
Background This study aimed to validate the performance of the Korean Gynecologic Oncologic Group (KGOG)-1024 risk model in predicting the risk of distant failure after chemoradiation in patients with locally advanced cervical cancer (LACC). Methods
Autor:
Michael T. McHale, Pratibha Binder, Jessica Jou, Steven C. Plaxe, Katherine Coakley, Cheryl C. Saenz, Lindsey M. Charo, Marianne Hom-Tedla, Ramez N. Eskander
Publikováno v:
Gynecologic Oncology. 163:299-304
Objective To describe the practice patterns and outcomes of patients with stage 3B endometrial cancer. Methods We queried the National Cancer Database for all surgically staged, stage 3 patients between 2012 and 2016. Patients who received any pre-op
Publikováno v:
Gynecologic Oncology. 162:631-637
Objective To investigate programmed cell death ligand 1 (PD-L1) expression patterns and define the associations among PD-L1, molecular subtypes, pathological features, and survival in a cohort of 833 patients with endometrial cancer, of whom approxim
Publikováno v:
Gynecol Oncol
Objective The objective of this study was to determine the prevalence of predictive biomarkers associated with FDA-approved therapies in molecularly defined adult-type ovarian granulosa cell tumors (aGCTs). Methods We performed a retrospective cross-
Autor:
Janice S. Kwon, Helena Abreu do Valle, Lesa Dawson, Gillian E. Hanley, Rona Cheifetz, Paramdeep Kaur
Publikováno v:
Gynecologic Oncology. 162:707-714
Objective Examine the risk of cardiovascular disease (CVD) following risk reducing bilateral salpingo-oophorectomy (RRBSO) among women with BRCA mutations. Methods In this retrospective population-based study in British Columbia, Canada, between 1996
Publikováno v:
Gynecologic Oncology. 162:674-678
5552 Background: It has long been identified that black women with ovarian cancer have worse overall survival when compared to white women. Disparities in the adherence to NCCN guideline-directed treatment and socioeconomic characteristics may be res
Publikováno v:
Gynecologic Oncology. 162:763-769
The goal of the study was to confirm whether preoperative controlling nutritional status (CONUT) was a prognostic factor in early-stage cervical cancer patients with high-risk factors after surgery and postoperative concurrent chemoradiotherapy (CCRT
Autor:
Molly Morton, Max Horowitz, Roberto Vargas, Laura M. Chambers, Peter G. Rose, Julia Chalif, Morgan Gruner, Anna Chichura, Danielle B. Chau, Robert Debernardo, Chad M. Michener, Anthony B. Costales, Meng Yao
Publikováno v:
Gynecologic Oncology. 162:368-374
To evaluate the impact of frailty on postoperative complications following cytoreductive surgery (CRS) with hyperthermic intra-peritoneal chemotherapy (HIPEC) in women with advanced or recurrent gynecologic cancer.An IRB-approved single-institution p
Autor:
Annamaria Ferrero, Giorgio Valabrega, M. Di Maio, U. De Giorgi, Gloria Mittica, Massimo Aglietta, L. Zavallone, Dionyssios Katsaros, A. Farolfi, Silvia Gemmiti, Fulvio Borella, E. Ghisoni, Michela Villa, Giulia Scotto, S. Mangiacotti, G. Giannone, Barbara Pasini, Margherita Turinetto, Valentina Tuninetti, Stefano Cosma
Publikováno v:
Gynecologic Oncology. 162:80-87
Background Hypersensitivity reactions (HSRs) to platinum are an important issue in the treatment of patients (pts) with ovarian cancer (OC). Germline BRCA mutations have been proposed as a risk factor. We aimed at evaluating the incidence and severit